Lilly's Jardiance meets main goal of two diabetes trials

(Reuters) - Eli Lilly& Co said on Monday that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing it in patients with type 1 diabetes.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news